rethinkTHC Search
Menu
Study breakdown

THC impairs short-term memory through a specific protein signaling pathway in the hippocampus

Animal StudyModerate evidence
The takeaway

Researchers identified protein kinase C (PKC) signaling in the hippocampus as the specific mechanism through which THC disrupts short-term memory in mice, separate from the pathway causing long-term memory impairment.

Read this if you want to understand the science behind why cannabis affects your short-term memory.

PKC blockers completely prevented THC-induced short-term memory impairment in mice

What the researchers found

Using a novel object recognition test in mice, researchers dissected the molecular mechanisms behind THC's effects on memory and made a key discovery: short-term and long-term memory impairment from THC operate through entirely different molecular pathways.

THC impaired short-term memory specifically through activation of protein kinase C (PKC) in the hippocampus. When researchers blocked PKC either systemically or directly in the hippocampus before THC administration, the short-term memory impairment was completely prevented. However, the same PKC blockers did not protect against long-term memory impairment.

Conversely, blocking mTOR (mammalian target of rapamycin), a pathway previously known to mediate THC's long-term memory effects, did not prevent the short-term memory deficit.

At the molecular level, THC caused a transient increase in PKC phosphorylation in the hippocampus, which paralleled the timing of cognitive impairment. THC also enhanced phosphorylation of neurogranin, a postsynaptic protein involved in synaptic plasticity, in a PKC-dependent manner.

Why it matters

Understanding the specific molecular mechanism behind THC's memory-impairing effects opens the door to developing interventions that could prevent cognitive side effects while preserving therapeutic benefits. The discovery that short-term and long-term memory impairment use different pathways suggests that targeted approaches could potentially block one without affecting the other.

The numbers in context

PKC inhibitors prevented THC-induced short-term memory impairment. mTOR inhibitors prevented long-term but not short-term memory impairment. Transient PKC phosphorylation increase observed in hippocampus after THC. PKC-dependent neurogranin phosphorylation enhanced by THC. PKC-theta identified as a potential mediating isoform.

How the study worked

Mice were tested on a novel object recognition memory paradigm. THC was administered systemically, and PKC inhibitors or mTOR inhibitors were given either systemically or directly into the hippocampus via microinjection. Immunoblot analysis measured PKC phosphorylation, PKC isoform expression, and neurogranin phosphorylation in hippocampal tissue.

What this study cannot tell us

This is a mouse study, and the specific PKC pathways may function differently in human hippocampal neurons. The novel object recognition task captures only one dimension of memory. PKC inhibitors used are research tools, not clinical drugs. The study used acute THC exposure and results may differ with chronic use.

How to read the evidence

This is a well-designed mechanistic animal study using multiple approaches (genetic, pharmacological, biochemical), providing moderate evidence for a specific molecular mechanism.

When this study was published

Published in 2018. Research on molecular mechanisms of THC-induced cognitive impairment continues.

The bigger picture

This study adds molecular precision to our understanding of cannabis-related cognitive impairment. Rather than viewing THC's memory effects as a single phenomenon, this work shows they involve distinct signaling cascades that could potentially be targeted independently, moving toward cannabis-based medicines that work without impairing memory.

Questions still open

  • Could PKC inhibitors be co-administered with therapeutic cannabis to prevent short-term memory side effects? Does chronic cannabis use cause lasting changes in hippocampal PKC signaling? Is the PKC-theta isoform a viable drug target for preventing THC-induced memory impairment?

Common questions

Why does THC affect short-term memory?
This study found that THC activates protein kinase C (PKC) in the hippocampus, the brain region critical for memory formation. This activation disrupts normal synaptic signaling, specifically by altering the phosphorylation of neurogranin, a protein involved in memory processes.
Could the memory effects of THC be blocked?
In mice, blocking PKC completely prevented THC-induced short-term memory impairment. This suggests it is theoretically possible to develop interventions that prevent memory side effects while preserving other cannabinoid effects, though this has not been tested in humans.

Read the original research

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(5), 1021-1031

Citation

Busquets-Garcia, Arnau; Gomis-González, Maria; Salgado-Mendialdúa, Victòria; Galera-López, Lorena; Puighermanal, Emma; Martín-García, Elena; Maldonado, Rafael; Ozaita, Andrés. (2018). Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(5), 1021-1031. https://doi.org/10.1038/npp.2017.175

Explore the wider topic